Bioelectronics: Nanovesicle-Based Bioelectronic Nose for the Diagnosis of Lung Cancer from Human Blood (Adv. Healthcare Mater. 3/2014)

Authors

  • Jong Hyun Lim,

    1. School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul, Korea
    Search for more papers by this author
  • Juhun Park,

    1. Department of Physics and Astronomy, Seoul National University, Seoul, Korea
    Search for more papers by this author
  • Eun Hae Oh,

    1. School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul, Korea
    Search for more papers by this author
  • Hwi Jin Ko,

    1. School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul, Korea
    Search for more papers by this author
  • Seunghun Hong,

    Corresponding author
    1. Department of Physics and Astronomy, Seoul National University, Seoul, Korea
    2. Department of Biophysics and Chemical Biology, Seoul National University, Seoul, Korea
    • Seunghun Hong, Department of Physics and Astronomy, Seoul National University, Seoul 151-742 Korea

      Tai Hyun Park, School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul 151-742 Korea

    Search for more papers by this author
  • Tai Hyun Park

    Corresponding author
    1. School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul, Korea
    • Seunghun Hong, Department of Physics and Astronomy, Seoul National University, Seoul 151-742 Korea

      Tai Hyun Park, School of Chemical and Biological Engineering, Bio-MAX Institute, Seoul National University, Seoul 151-742 Korea

    Search for more papers by this author

Abstract

image

A human nose-mimetic diagnosis system that can distinguish the odor of a lung cancer biomarker is developed by Seunghun Hong, Tai Hyun Park, and team on page 360. Nanovesicles containing human olfactory receptors are combined with carbon nanotubes in order to smell the biomarker from human blood plasma sensitively and selectively without any pretreatment processes.

Ancillary